Archives: Agenda
Chairperson’s opening remarks
Registration and refreshments
Leveraging electronic tools for ePRO Success: a site and patient-centric approach to clinical study success
- Digital patient engagement tools drive compliance: a web-based electronic patient-reported outcome platform together with an automated reminder system and multi-device accessibility enabled 98% of participants to complete visits with minimal follow-up, demonstrating how digital tools can engage diverse patient populations, including older demographics, while reducing site workload
- Integrated electronic payment system eliminates barriers: connecting an ePRO platform with digital payment solutions through API integrations ensures immediate participant compensation with multiple payment options (PayPal, Venmo, direct deposit), achieving 97%+ payment claim rates and preventing the participant dropout issues common with traditional prepaid card systems
PANEL DISCUSSION Cutting through AI noise by sharing real clinical operations use cases and controls
- Comparing validated use cases across feasibility, monitoring, and documentation
- Defining guardrails for privacy, bias, and human oversight
- Identifying where AI adoption increases risk more than it reduces work
Moderator
Peter Horwich, President, Lot 10
Building cybersecurity evidence into clinical and lifecycle planning for connected devices
- Translating cybersecurity expectations into clinical risk and user impact
- Planning evidence for resilience claims and update pathways
- Preparing submission-ready documentation and traceability
FIRESIDE CHAT Proving digital workflow value by simplifying consent and participant experience
- Reducing friction in consent and re-consent while protecting comprehension
- Designing participant communications that improve retention
- Auditing usability and documentation to avoid avoidable noncompliance
Chair: Charlie Whelan, Senior Director of Consulting, Medical Devices, GlobalData
PANEL DISCUSSION Balancing speed vs evidence: defining what ‘enough’ clinical data looks like
- Avoiding over-collection of data that delays timelines without adding value
- Understanding where regulators expect more vs where lean approaches are acceptable
- Sharing real examples of underpowered vs overengineered studies and their impact
Moderator
Aneela Idnani, President, HabitAware
Lunch & Networking
Beyond the protocol: syncing the site-sponsor-CRO triad for streamlined study execution
- Synchronizing the sponsor, CRO, and site
- Streamlining communication via defined roles and responsibilities
- Stabilizing study teams through proactive, strategic personnel continuity
- Empowering sites with transparent practices and user-friendly solutions